Certuity’s Agios Pharmaceuticals AGIO Stock Holding History

Certuity’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,000	Closed	-$191K	–	175
2019 Q4	$191K	Buy	+4,000	New	+$151K	0.09%	168

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Certuity's AGIO Position: Q1 2020 in Review

Certuity sold out of Agios Pharmaceuticals (AGIO) in Q1 2020, closing a stake of 4,000 shares — an estimated $191K sold.

Certuity first reported a position in AGIO in Q4 2019 and held it in 1 quarter. The position peaked at $191K in Q4 2019. 197 funds tracked by Wall St. Rank hold AGIO as of Q1 2020.

Certuity reported no remaining Agios Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Certuity sold 4,000 Agios Pharmaceuticals shares in Q1 2020, an estimated $191K.
Certuity first reported a position in Agios Pharmaceuticals in Q4 2019 and held it in 1 quarter.
Certuity's Agios Pharmaceuticals position peaked at $191K in Q4 2019.
197 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2020.

Based on Certuity's 13F filing for Q1 2020, filed 13 Apr 2020.